辉瑞在第二季度的盈利预期中超额，提高了2025年的盈利指引，并维持了股息。 Pfizer beat earnings estimates in Q2, raised 2025 guidance, and maintained its dividend.

Pfizer Inc.报告第二季度的收益为每股0.87美元,比重估计为8美元,但收入为166.5亿美元,略微超出预期。 Pfizer Inc. reported second-quarter earnings of $0.87 per share, beating estimates by $0.08, though revenue of $16.65 billion slightly missed expectations. 该公司将其2025年全年收入指导提高到每股3.00至3.15美元,并保持6.7%的股息收益,季度支付额为0.43美元。 The company raised its full-year 2025 earnings guidance to $3.00–$3.15 per share and maintained a 6.7% dividend yield with a $0.43 quarterly payout. 机构投资者,包括韩国投资公司CORP和Sumitomo Mitsui金融集团,增加了它们的股份。 Institutional investors, including Korea Investment CORP and Sumitomo Mitsui Financial Group, increased their stakes. Pfizer的股票市场上限为1,460.21亿美元,一致的“稳住”评级,目标价格为28.39美元。 Pfizer’s stock has a market cap of $146.21 billion, a consensus “Hold” rating, and a target price of $28.39.